Beazley, the leading specialty insurer, has announced Paul Bantick as Chief Underwriting Officer, following the decision by Bob Quane to retire. Mr Bantick will report to Adrian Cox, CEO of Beazley,… Read More
The Terry Fox Research Institute (TFRI) recently made updates to its Board of Directors. Dr. John Bell, a driving force in the development of virus-based cancer therapies and longtime TFRI… Read More
KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces the appointment of Michael Shankman, CPA, as Chief Financial Officer… Read More
Like whisky (smoky, fruity) or wine (bright, earthy), cannabis has a wide range of aromas. A new Genome BC-funded project, in partnership with Aurora Cannabis Inc. and researchers from the… Read More
Target enrollment in the chronic cohort close to completion Vancouver, BC – NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of… Read More
